Stay updated on APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.

Latest updates to the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page
- Check3 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03500549. Core information such as the study title, conditions, interventions, eligibility criteria, and locations appears unchanged.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check32 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%

- Check39 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

- Check54 days agoChange DetectedUpdated the page to revision v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element, a minor UI change.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page has updated the publication date of a study on Pegcetacoplan from July 28, 2025, to September 2025, reflecting the latest version of the research. Additionally, the revision number has been updated from v3.0.0 to v3.0.1.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of detailed facility names and locations, as well as new research references related to paroxysmal nocturnal hemoglobinuria. Notably, the previous mentions of locations and terms have been removed, indicating a shift in focus or a reorganization of content.SummaryDifference11%

Stay in the know with updates to APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.